Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HBME-1

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid carcinoma and nodular thyroid lesions
Background: Carcinomas of the thyroid follicular epithelium are the most common cancers of the endocrine system. In the diagnosis… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2015
2015
Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
INTRODUCTION The pathological diagnosis of papillary thyroid carcinoma (PTC) is generally easy on routine sections stained with… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
2015
2015
TROP‐2 expression in papillary thyroid cancer: a preliminary cyto‐histological study
TROP‐2 (human trophoblast cell surface marker) is a gene‐related protein expressed in trophoblastic cells, which is also present… Expand
Review
2015
Review
2015
Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma
This study examined the association between hector battifora mesothelial antigen-1 (HBME-1) expression and papillary thyroid… Expand
  • figure 1
  • table 2
  • table 1
  • table 3
  • figure 2
2014
2014
Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto…
  • Heng Ma, J. Yan, +5 authors N. Li
  • International journal of clinical and…
  • 2014
    • Corpus ID: 24232964
The aim of this study was to evaluate the expression of papillary thyroid carcinoma (PTC)-associated tumor markers in follicular… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Review
2014
Review
2014
Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma.
OBJECTIVE To assess usefulness of cytokeratin 19 (CK19), thyroperoxidase (TPO), Hector Battifora mesothelial epitope-1 (HBME-1… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2009
Highly Cited
2009
Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy
Background: Fine needle aspiration biopsy (FNAB) is a common and excellent procedure for the evaluation of thyroid lesions that… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2007
Highly Cited
2007
Diagnostic Value of Galectin-3, HBME-1, Cytokeratin 19, High Molecular Weight Cytokeratin, Cyclin D1 and p27kip1 in the Differential Diagnosis of Thyroid Nodules
The distinction between benign and malignant thyroid tumors is critical for the management of patients with thyroid nodules. We… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2001
Highly Cited
2001
Immunohistochemical Diagnosis of Papillary Thyroid Carcinoma
In thyroid, the diagnosis of papillary carcinoma (PC) is based on nuclear features; however, identification of these features is… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Highly Cited
1997
Highly Cited
1997
HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma.
The monoclonal antibody, HBME-1, generated against the microvillous surface of mesothelial cells, has been shown to have… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE